Hydrogen Research Study
← Back to Research Library
Human clinical evidenceCase report or case seriesHydrogen inhalation

Brain Metastases Completely Disappear in Non-Small Cell Lung Cancer Using Hydrogen Gas Inhalation: A Case Report.

Chen J, Mu F, Lu T, Du D, Xu K · OncoTargets and therapy · 2019

Research-use notice

Independent study record

Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.

H2HUBB Research Library branded molecular hydrogen research image
Primary topic Cancer and Supportive Oncology Research
Evidence type Human clinical evidence
Publication type Case report or case series
Hydrogen method Hydrogen inhalation
hydrogen inhalation cancer supportive study 31908482 research summary

The publication “Brain Metastases Completely Disappear in Non-Small Cell Lung Cancer Using Hydrogen Gas Inhalation: A Case Report.” is organized in H2HUBB under the research focus hydrogen inhalation cancer supportive study 31908482. The publication is cited as Chen J, Mu F, Lu T, Du D, Xu K, OncoTargets and therapy, 2019. This case report or case series examined Brain Metastases Completely Disappear in Non-Small Cell Lung Cancer Using Hydrogen Gas Inhalation: A Case Report. The abstract describes hydrogen delivered as hydrogen inhalation; reported duration 28 months. This is an automated editorial draft based on the abstract and requires source review before publication.

Hydrogen inhalation cancer supportive study 31908482 overview

The main outcome was not fully reported in the available structured record and should be checked against the original source. Because this is human clinical evidence, relevance depends on participant selection, controls, sample size, treatment duration, adherence, outcome measures, and replication.

Study design and hydrogen intervention

Publication type: Case report or case series. Evidence type: Human clinical evidence. Blinding: Unknown. Control status: Unknown.

Delivery method: Hydrogen inhalation. Treatment duration: 28 months.

Reported findings and scientific interpretation

For this hydrogen inhalation cancer supportive study 31908482, the study record reports the following: No detailed finding statement was available for this record. Readers should consult the original publication before drawing conclusions.

These findings should be interpreted as one piece of evidence rather than as a stand-alone medical conclusion. Results can be influenced by the research model, study design, treatment protocol, sample size, outcome selection, statistical methods, and whether the findings have been independently reproduced.

How this research record was prepared

H2HUBB organizes bibliographic details, study design information, intervention data, outcomes, limitations, and safety notes from the available scientific source. Automated classification supports database organization, but it does not replace critical reading of the complete paper. Source identifiers, evidence labels, and delivery-method fields are retained so readers can verify the record and compare it with related publications. A missing field means the information was unavailable or not reported in the structured source; it should not be treated as a negative finding.

Limitations, safety, and original source

Limitations: Case-report evidence cannot establish causality or broad generalizability.

Safety: The abstract did not provide detailed safety or adverse-event information.

This H2HUBB page is an educational research record, not medical advice. Review the original scientific source for the complete methods and results. Continue exploring the H2HUBB Molecular Hydrogen Research Library to compare evidence types, delivery methods, and related topics.